RecruitingNCT05169892
Aquablation in Benign Prostatic Hyperplasia in Canada
Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).
Sponsor
Can-Am HIFU Inc.
Enrollment
25 participants
Start Date
Oct 9, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria5
- Primary diagnosis of Benign Prostate Hypertrophy (BPH)
- Male subjects of ≥ 18 years of age
- Candidate for Aquablation therapy as per clinical decision of Investigator
- Willing and able to accurately complete questionnaires
- Willing and able to provide signed and dated informed consent
Exclusion Criteria3
- Characteristics indicating a poor compliance with study protocol requirements.
- Disease or other health condition that is not suitable for this study.
- Unable or unwilling to provide signed informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREAquablation
Aquablation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05169892
Related Trials
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
NCT058789511 location
Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients
NCT074358441 location
Trial for Reliability of Urodynamics SysTem
NCT056947934 locations
The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study.
NCT075356194 locations
Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children
NCT059896464 locations